Ultrasound to assess complications due to intra‐abdominal lymphatic malformation

Hosokawa, Takahiro; Nemoto, Hidehiko; Tanami, Yutaka; Ishimaru, Tadayuki; Kawashima, Hiroshi

doi:10.1111/ped.14954

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Postoperative complications increase psychological stress and financial burden on caregivers. Surgery is no longer considered the first-line treatment now but remains irreplaceable in certain cases, including lesions resistant to sclerotherapy and oral medication therapy, and life-threatening conditions such as spontaneous rupture, obstruction, severe intra-cystic infection, and abdominal compartment syndrome ( 16 – 18 ).…”

Section: Discussionmentioning

confidence: 99%

Laparoscopic-assisted sclerotherapy in pediatric retroperitoneal lymphatic malformations

Shi,

Lv,

et al. 2024

Front. Pediatr.

View full text Add to dashboard Cite

BackgroundRetroperitoneal lymphatic malformations (LMs) are rare. Currently, the treatment of retroperitoneal LMs remains challenging. This study aimed to examine the safety and efficacy of laparoscopic-assisted sclerotherapy for retroperitoneal LMs in pediatric patients.MethodsWe retrospectively reviewed patients treated with laparoscopic-assisted sclerotherapy for retroperitoneal LMs in a single tertiary medical center between July 2020 and February 2023. Doxycycline was prepared into a solution with a concentration of 10 mg/ml for use in sclerotherapy. Demographic data, clinical features, details of management, and outcomes were collected and analyzed.ResultsA total of six patients, comprising three males and three females, were identified. The LMs were categorized into four macrocystic and two mixed-cystic types. The mean age and weight were 52.2 months (range, 11–108 months) and 20 kg (range, 12.5–27.5 kg), respectively. Three patients presented with abdominal pain or distension, while the other three patients were asymptomatic. All six patients underwent a total of eight sclerotherapy sessions. Two patients experienced intra-cystic hemorrhage and required a second sclerotherapy session. Only one patient presented with vomiting after sclerotherapy, which resolved spontaneously. Five patients met the complete response criteria, and one patient met the effective criteria. The mean reduction in lesion size was 92.3% (range, 69.9%–99.6%). No further complications or recurrence were recorded during follow-up.ConclusionLaparoscopic-assisted sclerotherapy is a safe and effective approach for treating retroperitoneal LMs. This technique is applicable for both macrocystic and mixed-cystic retroperitoneal LMs.

show abstract

Section: Discussionmentioning

confidence: 99%

Laparoscopic-assisted sclerotherapy in pediatric retroperitoneal lymphatic malformations

Shi,

Lv,

et al. 2024

Front. Pediatr.

View full text Add to dashboard Cite

show abstract

Laparoscopic assisted sclerotherapy in pediatric intra-abdominal cystic lymphatic malformations

Shi

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Sclerotherapy is an effective treatment for CLMs of the head and neck. However, Management of intra-abdominal cystic lymphatic malformations(CLMs) remains debates. The purpose of this study was to examine safety and efficacy of laparoscopic assisted sclerotherapy for intra-abdominal CLMs in pediatric patients. Methods We retrospectively reviewed the patients treated with laparoscopic assisted sclerotherapy for intra-abdominal CLMs at a single tertiary medical center between July 2020 and July 2022.The basic information and clinical data of maximal diameter, dose, reduction of lesion’s volume and complications were analyzed. The efficacy was assessed by comparing the pre-operative and post-operative cross-sectional images. Results 7 patients were included in this study and underwent a total of 9 sclerotherapy sessions. 4 patients were symptomatic and majored in abdominal pain. The primary sclerotherapy did not response in better clinical outcome in 2 patients due to intra-cystic hemorrhage and additional procedure were performed. Lesions in 6 patients reduced ≥90% in volume which met the complete response criteria. No further complications were recorded during the follow-up. Conclusions Laparoscopic assisted sclerotherapy is a safe and effective method of managing intra-abdominal CLMs. Laparoscopy could localize the origin of lesions and provides more accuracy and stabilization during the injection procedure.

show abstract

Ultrasound to assess complications due to intra‐abdominal lymphatic malformation

Cited by 2 publications

References 5 publications

Laparoscopic-assisted sclerotherapy in pediatric retroperitoneal lymphatic malformations

Laparoscopic-assisted sclerotherapy in pediatric retroperitoneal lymphatic malformations

Laparoscopic assisted sclerotherapy in pediatric intra-abdominal cystic lymphatic malformations

Contact Info

Product

Resources

About